Vanguard Group Inc Larimar Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,297,249 shares of LRMR stock, worth $14.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,297,249

Previous 2,537,489 9.47%

Holding current value

$14.3 Million

Previous $18.4 Million 18.21%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$6.3 - $10.68 $1.51 Million - $2.57 Million	-240,240 Reduced 9.47%	2,297,249 $15 Million
Q2 2024 Aug 13, 2024	BUY	$6.33 - $9.89 $1.07 Million - $1.68 Million	169,788 Added 7.17%	2,537,489 $18.4 Million
Q1 2024 May 10, 2024	BUY	$4.2 - $13.28 $3.83 Million - $12.1 Million	912,458 Added 62.7%	2,367,701 $18 Million
Q4 2023 Feb 14, 2024	BUY	$2.35 - $4.71 $64,662 - $129,600	27,516 Added 1.93%	1,455,243 $6.62 Million
Q3 2023 Nov 14, 2023	BUY	$3.08 - $4.49 $111,268 - $162,205	36,126 Added 2.6%	1,427,727 $5.64 Million
Q2 2023 Aug 14, 2023	BUY	$3.13 - $5.27 $313,597 - $528,006	100,191 Added 7.76%	1,391,601 $4.36 Million
Q1 2023 May 15, 2023	BUY	$4.0 - $6.68 $819,984 - $1.37 Million	204,996 Added 18.87%	1,291,410 $5.85 Million
Q4 2022 Feb 10, 2023	BUY	$2.73 - $5.08 $359,415 - $668,802	131,654 Added 13.79%	1,086,414 $4.49 Million
Q3 2022 Nov 14, 2022	BUY	$1.53 - $3.64 $678,827 - $1.61 Million	443,678 Added 86.81%	954,760 $3.06 Million
Q1 2022 May 13, 2022	SELL	$3.65 - $10.84 $54,607 - $162,177	-14,961 Reduced 2.84%	511,082 $2.07 Million
Q4 2021 Feb 14, 2022	BUY	$8.86 - $13.47 $1.03 Million - $1.56 Million	115,727 Added 28.2%	526,043 $5.68 Million
Q3 2021 Nov 12, 2021	SELL	$9.61 - $15.11 $2.44 Million - $3.84 Million	-254,054 Reduced 38.24%	410,316 $4.73 Million
Q2 2021 Aug 13, 2021	BUY	$8.0 - $15.2 $5.31 Million - $10.1 Million	664,370 New	664,370 $6.53 Million

Others Institutions Holding LRMR

# of Institutions

128

Shares Held

67.3M

Call Options Held

280K

Put Options Held

76.3K

View Full List

About Larimar Therapeutics, Inc.

Ticker LRMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,269,200
Market Cap $269M
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...

More about LRMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Larimar Therapeutics, Inc. Transaction History